Drug Shortage Report for MYLAN-BUDESONIDE AQ
Report ID | 23166 |
Drug Identification Number | 02230648 |
Brand name | MYLAN-BUDESONIDE AQ |
Common or Proper name | BUDESONIDE AQ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 100MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 165 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-04-16 |
Actual start date | 2018-04-16 |
Estimated end date | 2020-01-30 |
Actual end date | 2020-01-20 |
Shortage status | Resolved |
Updated date | 2020-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-22 | English | Compare |
v2 | 2017-09-22 | French | Compare |
v3 | 2017-09-23 | English | Compare |
v4 | 2017-09-28 | English | Compare |
v5 | 2017-09-28 | French | Compare |
v6 | 2017-10-01 | English | Compare |
v7 | 2017-10-11 | English | Compare |
v8 | 2017-10-11 | French | Compare |
v9 | 2017-10-12 | English | Compare |
v10 | 2017-11-03 | English | Compare |
v11 | 2017-11-03 | French | Compare |
v12 | 2017-11-07 | English | Compare |
v13 | 2017-11-07 | French | Compare |
v14 | 2017-11-08 | English | Compare |
v15 | 2017-11-08 | French | Compare |
v16 | 2017-11-10 | English | Compare |
v17 | 2017-11-10 | French | Compare |
v18 | 2017-11-15 | English | Compare |
v19 | 2017-11-15 | French | Compare |
v20 | 2017-11-16 | English | Compare |